Clinical trial
Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile (ESECTO)
NCT05369013 is registered in ClinicalTrials.gov with STADA, Spain as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study and Follow-up of the Clinical Effectiveness and Comparative Safety of Biosimilar Teriparatide in the Management of Postmenopausal or Senile (ESECTO)
- Lead sponsor
- STADA, Spain
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 15, 2021
- Completion date
- April 14, 2024
- Enrollment
- 188 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.